A clinical trial with long-term follow-up found that administering BCG vaccine during the active phase of COVID-19 appeared ...

Researchers from Helmholtz Munich and Ludwig-Maximilians-Universität (LMU) have identified a mechanism that may explain the ...

Long COVID, a sometimes debilitating illness, infects a third of those who get COVID. Scientists and doctors are scrambling ...

Researchers find that SARS-CoV-2 spike protein persists in the skull-meninges-brain axis, driving neuroinflammation, ...

A vaccine targeting the KP.2 variant of Covid-19 is expected to become available in the Czech Republic within weeks.

Researchers review the safety, efficacy, and considerations for COVID-19 vaccination in multiple sclerosis patients, ...

Covid-19 likely leaked from a Chinese laboratory, according to a two-year investigation into pandemic in the US.

Explore groundbreaking research linking SARS-CoV-2 spike protein accumulation to long-lasting brain effects in long COVID.

COVID-19 vaccination significantly reduced anxiety and depression in patients with idiopathic pulmonary fibrosis (IPF), ...

Australia’s first ever mRNA vaccine manufacturing facility is now operational in Melbourne, with locally made Moderna jabs ...

The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled study to determine the relative efficacy, safety, and immunogenicity of Vaxart’s oral pill COVID-19 vaccine ...

A new study reveals that the SARS-CoV-2 spike protein remains in brain-protective tissues and skull bone marrow for years after infection, potentially driving long COVID's neurological symptoms.